SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001640334-20-001052
Filing Date
2020-05-06
Accepted
2020-05-05 19:03:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 F-3/A nymx_f3a.htm F-3/A 14807
2 EX-5.1 nymx_ex51.htm EX-5.1 22626
  Complete submission text file 0001640334-20-001052.txt   38445
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-237564 | Film No.: 20850613
SIC: 2835 In Vitro & In Vivo Diagnostic Substances